Evidence map›Paper›PMID 42605493›Full record

ArticleCureus2026

Lower Eyelid Cutaneous Squamous Cell Carcinoma: Oncologic Resection and Reconstruction With a Mustardé Rotation Flap.

Laura S Domínguez Gamboa, Andrea I Herrera Sandoval, Lissette E Duran García, Guadalupe García Castelán, Brian Mitchel Colli Mas, Oscar M Menjivar Rivera

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura S Domínguez GamboaSurgery, Hospitales Regionales de Alta Especialidad, Merida, MEX.
Andrea I Herrera SandovalSurgery, Hospitales Regionales de Alta Especialidad, Merida, MEX.
Lissette E Duran GarcíaSurgery, Hospitales Regionales de Alta Especialidad, Merida, MEX.
Guadalupe García CastelánSurgery, Hospitales Regionales de Alta Especialidad, Merida, MEX.
Brian Mitchel Colli MasSurgery, Hospitales Regionales de Alta Especialidad, Merida, MEX.
Oscar M Menjivar RiveraOncology, Yucatan's Higher Speciality Hospital, Merida, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periocular cutaneous squamous cell carcinoma can lead to local invasion, recurrence, and regional dissemination; therefore, its management must combine complete oncological resection with a reconstruction that preserves ocular protection. We present the case of a 75-year-old male agricultural worker with an irregular, ulcerated lesion measuring approximately 10 × 12 mm on the lower eyelid, with a three-month evolution. No regional lymphadenopathy or clinical evidence of orbital involvement or metastatic disease was identified. A wide excision of the lesion was performed, resulting in a 30 × 15 mm defect, followed by immediate reconstruction using a Mustardé dermocutaneous rotation flap. The definitive histopathological examination confirmed a moderately differentiated squamous cell carcinoma (G2) without lymphovascular, perineural, or deep structure invasion, with negative surgical margins and a minimum distance of 9 mm. The immediate and outpatient postoperative course was favorable, demonstrating flap viability, continuity of the cutaneous coverage, and no evident early complications. This case demonstrates the integration of oncological resection with histological margin control and immediate reconstruction using a Mustardé flap for cutaneous defects of the lower eyelid.

Indexed as

cutaneous squamous cell carcinomaeyelid reconstructionlower eyelidmustardé flaponcologic resection

Identifiers

PMID42605493
PMCPMC13477805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.